Immucell (ICCC) Other Accumulated Expenses (2023 - 2026)

Immucell (ICCC) has 3 years of Other Accumulated Expenses data on file, last reported at $333710.0 in Q4 2025.

• Quarterly Other Accumulated Expenses rose 42.28% year-over-year to $333710.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $333710.0 (up 42.28% YoY) and the FY2025 annual result came in at $333710.0, up 42.28% from the prior year.
• Other Accumulated Expenses improved to $333710.0 in Q4 2025, from $264832.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $376112.0 in Q3 2024 to a low of $131539.0 in Q1 2025.
• A 3-year average of $240184.1 and a median of $234552.0 in 2024 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 42.28% in 2025, down 29.59% in 2025.
• Tracing ICCC's Other Accumulated Expenses over 3 years: stood at $192754.0 in 2023, then gained by 21.68% to $234552.0 in 2024, then soared by 42.28% to $333710.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $333710.0 (Q4 2025), $264832.0 (Q3 2025), and $147790.0 (Q2 2025), per Business Quant data.